medicamentos glp 1 🚨 LA NUEVA COMPETENCIA EN OBESIDAD ES ORAL: ORFORGLIPRON VS. WEGOVY®️ PILL Dos agonistas del receptor GLP-1 administrados una vez al día, pero con diferencias importantes. Orforglipron es una molécula pequeña no Weight-Loss Medications Are Effective for

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1RA) in high-risk patients with type 2 diabetes

Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances

This article has been updated by The Pharmaceutical Journal team and reviewed by the expert authors to ensure it remains relevant and up to date, following its original publication in December 2025

If you choose to consume diet soda occasionally, doing so in moderation within an otherwise balanced dietary pattern is unlikely to cause harm

214 As the use of GLP-1s grows, the need for long-term supportive health promotion (and not merely short-term weight reduction) through lifestyle efforts will equally rise, 91 and GMVs appear well suited for such efforts